Veeva's expanded manufacturing QC solutions to automate environmental sample collection and analysisPLEASANTON, Calif., Jan. 8, 2026 /PRNewswire/ -- Veeva Systems (NYSE: VEEV)...
BOSTON, Jan. 8, 2026 /PRNewswire/ -- IntelyCare, a leading technology-enabled healthcare staffing platform, today announced the acquisition of CareRev, the on-demand workforce...
TELUS Health's global scale and accelerating commercial momentum present compelling partnership opportunity VANCOUVER, BC, Jan. 8, 2026 /CNW/ - TELUS Corporation...
Guiding Leaders elevates dentists through leadership and business courses, executive coaching, and a thriving alumni network. NEWPORT BEACH, CALIFORNIA /...
Black Book® Q4 2025 flash survey finds behavioral health, post-acute, public health, and CBO connectivity still heavily manual, with fees...
NORTHAMPTON, MA / ACCESS Newswire / January 8, 2026 / Each year, the Curiosity Cube™, a mobile science lab from...
ST. PETERSBURG, FL / ACCESS Newswire / January 8, 2026 / SummaryAqua Sculpt has emerged as a significant topic of...
MESA, ARIZONA / ACCESS Newswire / January 8, 2026 / Medical Care Technologies Inc. (OTC PINK:MDCE) today announced that its...
Saxton will lead NCQA's Quality Solutions Group, strengthening federal collaboration to drive health transformation WASHINGTON, DC / ACCESS Newswire /...
WELLINGTON, FLORIDA / ACCESS Newswire / January 8, 2026 / Cellev8 Nutrition Inc., (OTCID:CELV) a leader in clinically validated antioxidant...
Conference Call to be Hosted on Monday, January 12 at 1:30 PM PT/4:30 PM ET FREMONT, CA / ACCESS Newswire...
~ New ADHD pipeline leverages TAAP™ and MPAR® technologies to improve safety for patients ~ SAN DIEGO, CALIFORNIA / ACCESS...
Seiga Ohmine to join as Chief Commercial Officer, Sharad Dubey as Chief Financial Officer and Patrick Lansky as Senior Vice...
Company Positioned for Strategic Transaction MALVERN, PA / ACCESS Newswire / January 8, 2026 / Toetal Solution, Inc., a Runway...
1H 2026 Catalyst Stack Anticipated to Validate Scalable, Off-the-Shelf CAR T in Oncology and Autoimmune Disease Interim Futility Analysis of...
Received $35.8 million in gross proceeds from Series B warrant exercises, including full exercise by Coastlands Capital, Frazier Life Sciences...
Company achieved significant commercial progress in 2025, generating approximately $378 million in product revenue1 IBSRELA achieved $274 million in revenue...
- First patient dosed in Phase 2 ASPEN-09-Breast trial evaluating evorpacept in combination with trastuzumab and physician’s choice of chemotherapy...
New Pharmacokinetic (PK) and Pharmacodynamic Data from Sub-Study in Phase III Trial Strengthens Scientific Basis for RenovoRx’s TAMP Therapy Platform...
– Preferential MOP agonists such as oxycodone are often required for effective management of moderate to severe pain but come...